🎉 We’re thrilled to join Wellcome Sanger Institute in celebrating the generation of 50 Petabases of genomic sequence data 🧬 Thank you for a great afternoon marking this milestone! It has been inspiring to reflect on over 30 years of world renowned research, and look to how we will continue to push the boundaries of genomic science in the future #50Pb #genomics #genetics #bigdata #cancerresearch
COSMIC (Catalogue of Somatic Mutations in Cancer)
Research
The world's largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer.
About us
Based at the Wellcome Sanger Institute, COSMIC is the world's most comprehensive resource for exploring the impact of somatic mutations in human cancer. All cancers arise as a result of the acquisition of mutations, many of which ultimately confer a growth advantage upon the cells in which they have occurred. There is a vast amount of information available in the published scientific literature about these changes. COSMIC provides researchers access to the world's knowledge of somatic mutations in human cancer in a single resource.
- Website
-
http://cancer.sanger.ac.uk/cosmic
External link for COSMIC (Catalogue of Somatic Mutations in Cancer)
- Industry
- Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge
- Type
- Nonprofit
- Founded
- 2004
- Specialties
- cancer genomics
Locations
-
Primary
Wellcome Genome Campus
Hinxton
Cambridge, GB
Employees at COSMIC (Catalogue of Somatic Mutations in Cancer)
Updates
-
We are excited to announce that COSMIC v101 will be released this month! Keep an eye on our socials throughout November for sneak peeks into this next update 🎉 🧬 #CancerResearch #Genomics
-
🎉 The COSMIC team is excited to attend Oxford Global's Nextgen Omics 2024 this week! 📣 Director of COSMIC Jon Teague is thrilled to be presenting a talk on using COSMIC for Precision oncology, where you can learn: Importance of effective data aggregation and management for precision oncology How COSMIC handles and curates vast amounts of gold standard genomic data How we ensure meaningful interpretation of genomic data Importance of standards and the role of AI 👋 Our commercial team will also be attending, and eager to help with any of your COSMIC queries! To set up a meeting, or ask any questions, get in contact with our Relationships Officer Zoe Sheard Using COSMIC for Precision Oncology 📅 Date: 23rd October 2024 🕐 Time: 14:25 📍 Location: Conference Room 2 #NextGenOmics24 #Genomics #Genetics #CancerResearch #Oncology
-
🌟 A huge thank you to everyone who joined us for our BioTechX talk, and a special thank you to QIAGEN Digital Insights for kindly sponsoring the talk! 🧬 It was inspiring to see so many people interested in the importance of data driven oncology, its role in the clinical setting and how we're working towards the future 💡 One of the key themes of this year's conference has been the critical role of high quality data in unlocking the full potential of AI/ML/LLM based tools to improve drug development and clinical development. High quality data and data accessibility has been at the very core of COSMIC’s mission since it's inception, as emphasised by our Director Jon Teague in his talk. We’re committed to delivering FAIR data, making it easily accessible and usable for everyone who needs it. By reducing time spent cleaning up data, users are empowered to focus on advancing their research. #BiotechX2024 #BigData #AI #CancerResearch #Genomics #Oncology #Knowledgebase
-
The COSMIC team is excited for another great day at BioTechX! 📣 Don’t miss our talk by Jon Teague, Director of COSMIC, today at 3:30 PM in Theatre 8 (Big Data in Oncology Track) 👋 Today we will be joining our commercial partner QIAGEN Digital Insights at their booth #328 where we look forward to connecting with you and answering any of your COSMIC quieries 🧬 We can’t wait to hear more insights on how harnessing AI is transforming R&D, data management and more, all while keeping patients at the heart of our mission #BiotechX2024 #BigData #Genomics #CancerResearch #AI #Oncology
-
Happy 10 year anniversary to Open Targets 🎉 The COSMIC team is excited for a day of insightful talks to celebrate ten years of collaboration, discovery and more! #OpenTargetsAt10 #Genetics #BigData #DrugDiscovery
-
🧬 The COSMIC team is looking forward to attending BioTechX Europe next week! Don't miss the talk by Director of COSMIC Jon Teague, where you’ll discover how our gold standard, FAIR knowledgebase can boost your pipelines and research (details below) 🚀 We will be joining our commercial partner, Qiagen Digital Insights at their booth #328 where we will be happy to discuss any of your queries about COSMIC. Reach out to our Head of Commercial Ilaria Fasanella, MSc, PhD or Relationships Officer Zoe Sheard to arrange a meeting 🗓️ Talk by Director of COSMIC, Jon Teague: Wednesday 9th October, 3:30pm-30:50pm Big Data in Oncology Track, Theatre 8 #BioTechX #CancerResearch #Bioinformatics #Biotechnology #Bigdata #Genomics
-
🧬 The COSMIC team is thrilled to be connecting with the academic community at #eSCAMPS2024 today 👋 If you’re here too, don’t forget to say hello and take part in our survey to have your say in the future COSMIC and take home some COSMIC goodies! #cancerresearch #genomics #database #bioinformatics #oncology #precisiononcology
-
The COSMIC team had a fantastic final day at #ESMO24 and we're sad to be leaving! 💡 We’ve enjoyed engaging with many potential collaborators and insightful talks. 🧬 Particular highlights from today were discussions on the importance of improved sequencing depth and larger patient cohorts, to deepen our insights into non-coding DNA as an emerging tool for prognosis. #ESMO24 #PrecisionOncology #MedicalOncology #CancerResearch #Genomics #noncodingDNA
-
We have had an incredible first day at #ESMO24! 🧬 It was inspiring to hear the strong advocacy for comprehensive whole genome sequencing in cancer patients, emphasising it’s critical role in prognosis and precision medicine. 💻 From histology and biomarker analysis, to monitoring recurrence and patient triage, discussions on optimising AI use across various fields in oncology were insightful and promising for the future of cancer care. #ESMO24 #PrecisionOncology #MedicalOncology #CancerResearch #Genomics